- Global Pharma News & Resources

Anatomic Pathology Market Set for Rapid Expansion in Asia-Pacific in Near Future

Valued at $17.4 billion in 2018, the global anatomic pathology market is predicted to reach a revenue of $24.3 billion by 2024. According to the forecast of P&S Intelligence, a market research company based in India, the market will exhibit a CAGR of 5.8% between 2019 and 2024. The prominent factors fueling the progress of the market are the rising prevalence of chronic diseases, the surging population of geriatric people, and rapid advancements and innovations in technologies.

Receive Sample Copy of this Report:

Apart from the aforementioned factor, the increasing incidence of chronic diseases such as heart diseases, kidney diseases, cancer, autoimmune diseases, and liver cirrhosis, is also propelling the growth of the anatomic pathology market. The occurrence rate of chronic diseases is skyrocketing in both low- and middle-income countries (LMICs) and high-income countries. According to the findings of the WHO, 9.6 million people all over the world lost their lives because of cancer in 2018.

Make an Enquiry before Purchase:

Between these, the disease diagnosis category is predicted to register the highest and the fastest growth in the market in the future years. This will be because of the soaring geriatric population and the rising incidence of chronic ailments among patients. The anatomic pathology market is also classified, on the basis of end user, into hospitals and clinics, diagnostic laboratories, academic and research organizations, and ambulatory surgical centers. Amongst these, the diagnostic laboratories recorded the highest growth in the past.

Editor Details

Last Updated: 21-Jul-2021